本文選題：經(jīng)皮腎鏡取石術(shù) + 單通道　； 參考：《山西醫(yī)科大學(xué)》2017年碩士論文

【摘要】：目的:系統(tǒng)評價單通道與多通道經(jīng)皮腎鏡取石術(shù)治療復(fù)雜性腎結(jié)石的安全性及療效。方法:計算機檢索Pub Med、維普、萬方和中國知網(wǎng),全面收集有關(guān)單通道經(jīng)皮腎鏡取石術(shù)與多通道經(jīng)皮腎鏡取石術(shù)治療復(fù)雜性腎結(jié)石的隨機對照及非隨機對照試驗,檢索時限自1990年1月至2016年9月。由2名評價者依照納入及排除標準選取試驗、找出數(shù)據(jù)材料和分析質(zhì)量,Meta分析工具使用RevMan 5.3進行。結(jié)果:共選入13篇文獻,涉及2053名患者。結(jié)果為:與單通道組相比,多通道組清石率較高[OR=0.33,95%CI(0.22~0.52),P0.00001],術(shù)中出血量較少[MD=10.53,95%CI(1.96~19.09),P=0.02],術(shù)后血紅蛋白下降量較大[MD=10.30;95%CI(5.38,15.24)P=0.0006],輸血人數(shù)較多[OR=0.51,95%CI(0.35~0.75),P=0.0007],術(shù)后并發(fā)癥發(fā)生率較高[OR=0.51,95%CI(0.36~0.72),P=0.0001],而在手術(shù)時間、住院時間、術(shù)后感染人數(shù)、術(shù)后血清肌酐變化方面分析比較差異均無統(tǒng)計學(xué)意義(P0.05)。結(jié)論:多通道經(jīng)皮腎鏡取石術(shù)的優(yōu)勢主要體現(xiàn)在清石率較高、術(shù)中出血量較少等方面;劣勢主要為術(shù)后血紅蛋白下降較大、輸血人數(shù)較多、并發(fā)癥發(fā)生率較高等方面。
[Abstract]:Objective: to evaluate the safety and efficacy of single channel and multi-channel percutaneous nephrolithotomy in the treatment of complex renal calculi. Methods: a computerized search of Pub Med, Weip, Wanfang and China Zhiwang was conducted to collect the randomized controlled and non-randomized controlled trials of single channel percutaneous nephrolithotomy and multichannel percutaneous nephrolithotomy for the treatment of complex renal calculi. The time limit for retrieval is from January 1990 to September 2016. According to the inclusion and exclusion criteria, two evaluators selected the data materials and analyzed the quality of meta-analysis using RevMan 5.3. Results: a total of 13 articles involving 2053 patients were selected. 緇撴灉涓，

本文編號：1892040